376 related articles for article (PubMed ID: 12368195)
1. CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.
Kristiansen G; Denkert C; Schlüns K; Dahl E; Pilarsky C; Hauptmann S
Am J Pathol; 2002 Oct; 161(4):1215-21. PubMed ID: 12368195
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors.
Choi YL; Kim SH; Shin YK; Hong YC; Lee SJ; Kang SY; Ahn G
Gynecol Oncol; 2005 May; 97(2):379-86. PubMed ID: 15863133
[TBL] [Abstract][Full Text] [Related]
3. CD24 expression is a new prognostic marker in breast cancer.
Kristiansen G; Winzer KJ; Mayordomo E; Bellach J; Schlüns K; Denkert C; Dahl E; Pilarsky C; Altevogt P; Guski H; Dietel M
Clin Cancer Res; 2003 Oct; 9(13):4906-13. PubMed ID: 14581365
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
6. The role of CD24 in various human epithelial neoplasias.
Lim SC; Oh SH
Pathol Res Pract; 2005; 201(7):479-86. PubMed ID: 16164042
[TBL] [Abstract][Full Text] [Related]
7. Expression and amplification of eIF-5A2 in human epithelial ovarian tumors and overexpression of EIF-5A2 is a new independent predictor of outcome in patients with ovarian carcinoma.
Yang GF; Xie D; Liu JH; Luo JH; Li LJ; Hua WF; Wu HM; Kung HF; Zeng YX; Guan XY
Gynecol Oncol; 2009 Feb; 112(2):314-8. PubMed ID: 19054548
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival.
Weichert W; Denkert C; Burkhardt M; Gansukh T; Bellach J; Altevogt P; Dietel M; Kristiansen G
Clin Cancer Res; 2005 Sep; 11(18):6574-81. PubMed ID: 16166435
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of immunohistochemical estimation of CD24 and Ki67 expression in cisplatin and paclitaxel treated ovarian carcinoma patients.
Surowiak P; Materna V; Kłak K; Spaczyński M; Dietel M; Kristiansen G; Lage H; Zabel M
Pol J Pathol; 2005; 56(2):69-74. PubMed ID: 16092668
[TBL] [Abstract][Full Text] [Related]
10. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas.
Salvesen HB; Iversen OE; Akslen LA
Clin Cancer Res; 1998 Nov; 4(11):2779-85. PubMed ID: 9829742
[TBL] [Abstract][Full Text] [Related]
11. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.
Kristiansen G; Schlüns K; Yongwei Y; Denkert C; Dietel M; Petersen I
Br J Cancer; 2003 Jan; 88(2):231-6. PubMed ID: 12610508
[TBL] [Abstract][Full Text] [Related]
12. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
Shigemasa K; Tian X; Gu L; Tanimoto H; Underwood LJ; O'Brien TJ; Ohama K
Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.
Denkert C; Köbel M; Pest S; Koch I; Berger S; Schwabe M; Siegert A; Reles A; Klosterhalfen B; Hauptmann S
Am J Pathol; 2002 Mar; 160(3):893-903. PubMed ID: 11891188
[TBL] [Abstract][Full Text] [Related]
15. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
[TBL] [Abstract][Full Text] [Related]
16. CD24 expression has a prognostic impact in breast carcinoma.
Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896
[TBL] [Abstract][Full Text] [Related]
17. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of dedicator of cytokinesis I (Dock180) in ovarian cancer correlated with aggressive phenotype and poor patient survival.
Zhao F; Siu MK; Jiang L; Tam KF; Ngan HY; Le XF; Wong OG; Wong ES; Chan HY; Cheung AN
Histopathology; 2011 Dec; 59(6):1163-72. PubMed ID: 22175896
[TBL] [Abstract][Full Text] [Related]
19. CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancer.
Ahmed MA; Al-Attar A; Kim J; Watson NF; Scholefield JH; Durrant LG; Ilyas M
J Clin Pathol; 2009 Dec; 62(12):1117-22. PubMed ID: 19946098
[TBL] [Abstract][Full Text] [Related]
20. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
